TINA BILLBERRY: Open Payments
NPI 1437789203 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 59 payments from 15 companies in 2025. Trend: 2023 $1,654 · 2024 $1,303 · 2025 $1,054
Food & beverage: $1,054
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $327 |
| ABBVIE INC. | 15 | $238 |
| Lilly USA, LLC | 11 | $130 |
| Novo Nordisk Inc | 6 | $100 |
| PFIZER INC. | 2 | $56 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Averitas Pharma Inc. | 1 | $22 |
| Seqirus USA Inc | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: FARXIGA, QULIPTA, MOUNJARO, Ozempic, AIRSUPRA, UBRELVY, BREZTRI, VRAYLAR.
Industry payments across LA — which companies pay providers there.
